Abstract:Background: Prostate cancer (PCa) is a prevalent malignancy among men, primarily originating from the prostate epithelium. It ranks first in global cancer incidence and second in mortality rates, with a rising trend in China. PCa's subtle initial symptoms, such as urinary issues, necessitate diagnostic measures like digital rectal examination, prostate-specific antigen (PSA) testing, and tissue biopsy. Advanced PCa management typically involves a multifaceted approach encompassing surgery, radiation, chemotherapy, and hormonal therapy. The involvement of aging genes in PCa development and progression, particularly through the mTOR pathway, has garnered increasing attention. Methods: This study aimed to explore the association between aging genes and biochemical PCa recurrence and construct predictive models. Utilizing public gene expression datasets (GSE70768, GSE116918, and TCGA), we conducted extensive analyses, including Cox regression, functional enrichment, immune cell infiltration estimation, and drug sensitivity assessments. The constructed risk score model, based on aging-related genes (ARGs), demonstrated superior predictive capability for PCa prognosis compared to conventional clinical features. High-risk genes positively correlated with risk, while low-risk genes displayed a negative correlation. Results: An ARGs-based risk score model was developed and validated for predicting prognosis in prostate adenocarcinoma (PRAD) patients. LASSO regression analysis and cross-validation plots were employed to select ARGs with prognostic significance. The risk score outperformed traditional clinicopathological features in predicting PRAD prognosis, as evidenced by its high AUC (0.787). The model demonstrated good sensitivity and specificity, with AUC values of 0.67, 0.675, 0.696, and 0.696 at 1, 3, 5, and 8 years, respectively, in the GEO cohort. Similar AUC values were observed in the TCGA cohort at 1, 3, and 5 years (0.67, 0.659, 0.667, and 0.743). The model included 12 genes, with high-risk genes positively correlated with risk and low-risk genes negatively correlated. Conclusions: This study presents a robust ARGs-based risk score model for predicting biochemical recurrence in PCa patients, highlighting the potential significance of aging genes in PCa prognosis and offering enhanced predictive accuracy compared to traditional clinical parameters. These findings open new avenues for research on PCa recurrence prediction and therapeutic strategies.

Differences in Phenotype and Gene Expression of Prostate Stromal Cells from Patients of Varying Ages and Their Influence on Tumour Formation by Prostate Epithelial Cells

Effect of Prostatic Stromal Cells from Varying Ages on the Growth of Prostate Epithelial Cells

[Characterization of Stromal Cell Cultures from the Prostatic Peripheral Zone of Men at Different Ages].

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells

[Differential Gene Expressions in the Stromal Cells of the Human Prostate Peripheral Zone in Males of Different Ages].

Ultrastructural Difference of Stromal Cells from Normal Human Prostate Peripheral Zone of Varying Ages

Androgen Receptors Expressed by Prostatic Stromal Cells Obtained from Younger Versus Older Males Exhibit Opposite Roles in Prostate Cancer Progression

Aging Up-Regulates ARA55 in Stromal Cells, Inducing Androgen-Mediated Prostate Cancer Cell Proliferation and Migration

Tumor Formation of Prostate Cancer Cells Influenced by Stromal Cells from the Transitional or Peripheral Zones of the Normal Prostate.

Different Biological Characteristics of Different Prostatic Zonal Primary Stromal Cells and Cancer Associated Stromal Cells,as Well As Their Different Effects on Prostate Cancer Cell Line C4-2B

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Single-cell analysis reveals alternations between the aged and young mice prostates

The Proliferation of Prostate Cancer Cell Line PC-3 Inhibited by the Normal Prostate Stromal Cells in Vitro

[Effects of Stromal Cells Derived from the Normal Prostate on the Glycolysis of Prostate Cancer Cells].

Normal Prostate‐derived Stromal Cells Stimulate Prostate Cancer Development

Differential Effects of Peripheral and Transitional Prostatic Stromal Cells on Tumorigenesis.

Differential Expression of Genes in Co-Cultured Versus Separately Cultured Fibroblasts and Epithelial Cells from Human Benign Hyperplastic Prostate Tissues.

Lim Domain Only 2 Over-Expression In Prostate Stromal Cells Facilitates Prostate Cancer Progression Through Paracrine Of Interleukin-11

Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences

Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis

Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression.